CoChat

Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery

· 2005 · New England Journal of Medicine
Cited by 34

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

n engl j med 353;20 www.nejm.org november 17, 2005 2192 to the editor: The causal links between bariatric surgery and pancreatic nesidioblastosis are unclear. Service et al. (July 21 issue)1 suggest a link between nesidioblastosis and glucagon-like peptide 1 (GLP-1), since GLP-1 causes beta-cell expansion in animal models of diabetes. GLP-1 and the incretin mimetic exenatide enhance insulin secretion in a glucose-dependent manner.2,3 Similarly, incretin-induced beta-cell expansion appears to be glucose-dependent. It is relevant that studies of two years’ duration in normal mice and rats of exenatide at doses of more than 100 times those given to humans showed no pathological changes in the islets (data on file, Amylin Pharmaceuticals); a study of nine months’ duration in healthy cynomolgus monkeys at doses of more than 400 times those used in humans showed minimal-to-mild islet hypercellularity with no increase in islet size (data on file, Amylin Pharmaceuticals). There have been no reports of recurrent, severe hypoglycemia or of nesidioblastosis in patients with type 2 diabetes mellitus during more than 2670 patient-years of exposure to exenatide. Given that neither experimental nor clinical evidence suggests that GLP-1 or exenatide induces nesidioblastosis, and given the multiple hormonal and metabolic changes that occur after bariatric surgery,4-6 we would suggest that the link between bariatric surgery and nesidioblastosis is multifactorial. Further study may lead to insights concerning the regulation of beta-cell function and growth. Thomas Carpenter, Ph.D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm200511173532017

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 34

Metadata

Venue
New England Journal of Medicine
Published
2005-11-17
Volume
353
Issue
20
Pages
2192-2194
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2407631239
Cited by
34
References
2
FWCI
3.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery. https://app.cochat.ai/papers/10.1056/nejm200511173532017
The paper
Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery. (2005). New England Journal of Medicine. https://doi.org/10.1056/nejm200511173532017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.